ON THE CASE: Optimizing Outcomes in Psoriatic Arthritis
Released On
February 17, 2023
Expires On
February 17, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Dermatology, Primary Care, Rheumatology
Topic(s)
Psoriatic Arthritis
This activity is jointly provided by Partners for Advancing Clinical Education (PACE) and Catamount Medical Education.
This activity is supported by an independent educational grant from AbbVie.
Credit Available
- Physicians — maximum of 0.50 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of rheumatologists, dermatologists, primary care physicians, and other health care professionals who care for patients with psoriatic arthritis (PsA).
Program Overview
A 30-minute online, interactive module designed to lead clinicians through a case-based learning experience intended to mimic real-life clinical interactions. Three cases involving psoriatic arthritis (PsA) will be presented, focusing on considerations in treatment selection, strategies for monitoring disease activity and treatment response, and evidence and best practices for adjusting therapy in response to changes in disease activity.
Learning Objectives
- Discuss factors to consider when initiating treatment for newly diagnosed PsA
- Apply evidence-based strategies for monitoring disease activity and treatment response
- Adjust therapy in response to changes in disease activity over time with the goal of optimizing outcomes and quality of life for individual patients
Faculty
Philip Mease, MD, MACR
Director, Rheumatology Research
Swedish Medical Center/Providence St Joseph Health
Seattle, Washington
Clinical Professor
University of Washington School of Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Catamount Medical Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of an ineligible company.
Faculty Disclosure
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
- Philip Mease, MD, MACR
- Consulting Fees: AbbVie, Acelyrin, Aclaris, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Inmagene, Janssen, Moonlake, Novartis, Pfizer, Sun Pharma, UCB
- Speaker Honoraria: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, UCB
- Grant Funding Fee: AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Galapagos, Gilead, Janssen, Novartis, Pfizer, Sun Pharma, UCB
Susan Denner, MD, MS, Medical Director, Catamount Medical Education has no relevant financial relationships to report.
Danielle Ellinas, Director of Operations, Catamount Medical Education has no relevant financial relationships to report.
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Instructions for Participation and Credit
This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
- Read the CE information
- Complete the pretest
- View the content
- Complete the posttest and the evaluation form
A score of 66% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Upon completion of the evaluation, your certificate will be emailed to you.
The estimated time to complete the activity is 30 minutes.
This activity was originally released on February 17, 2023, and is eligible for credit through February 17, 2024.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Our Policy on Privacy
PACE and Catamount Medical Education, LLC respect your privacy. All personal information that is provided to Catamount Medical Education, LLC is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the post-test and evaluation results for CME credit. This information is provided to activity collaborators for the purposes of CME recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC has full permission to provide this information.
For each visitor to this Web site, our Web server automatically recognizes information such as the visitor’s IP address. Catamount Medical Education, LLC safeguards against the loss, misuse, or alteration of information that we have collected in this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.
For information about the accreditation of this activity, please visit www.partnersed.com.